Related Experiment Video

Updated: Aug 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumonia in young children with homozygous sickle cell disease: risk and clinical features

K De Ceulaer, K W McMullen, G H Maude

    European Journal of Pediatrics
    |September 1, 1985
    PubMed

    Insights

    Children with sickle cell disease (SS) experience significantly higher rates of pneumonia after 8 months of age compared to healthy children (AA genotype). This increased prevalence of pneumonia in SS disease leads to more severe clinical courses and higher mortality.

    Area of Science:

    • Pediatric Hematology
    • Infectious Diseases
    • Genetics

    Background:

    • Sickle cell disease (SS) is a genetic blood disorder affecting hemoglobin.
    • Pneumonia is a common and serious infection in children.
    • Understanding pneumonia risk in SS disease is crucial for early intervention.

    Purpose of the Study:

    • To compare the incidence and clinical features of pneumonia in children with homozygous sickle cell (SS) disease versus those with normal hemoglobin (AA) genotype.
    • To assess the long-term risk and severity of pneumonia in pediatric sickle cell disease.

    Main Methods:

    • A cohort study followed children with sickle cell disease (SS) and age/sex-matched controls (AA genotype) from birth.
    • Survival curve analysis was used to compare pneumonia incidence between genotypes.
    • Clinical features, bacteriological, and radiological investigations were compared.

    Main Results:

    • Pneumonia incidence was similar until 8 months, then significantly higher in SS disease (relative risk >4 by 4 years).
    • Children with SS disease experienced more frequent and multiple pneumonia episodes.
    • Pneumonia in SS disease led to increased hospital admissions, longer duration, and all recorded mortality.

    Conclusions:

    • Children with sickle cell disease (SS) have a substantially increased prevalence of pneumonia, including recurrent episodes.
    • Pneumonia in pediatric SS disease presents a more severe clinical course compared to children with normal hemoglobin (AA).
    • These findings highlight the critical need for vigilant monitoring and management of respiratory infections in children with sickle cell disease.

    More Related Videos

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

    Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

    Published on: March 6, 2019

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    Related Concept Videos

    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Pneumonia I: Introduction01:29

    Pneumonia I: Introduction

    Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...